arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

Catheter Precision, Inc.

VTAK
$0.15 ▲ +0.01 (+3.39%) at close
Healthcare ·Surgical & Medical Instruments & Apparatus ·USSurgical & Medical Instruments & Apparatus
38 Visible periods
31 Metrics
Peer-ranked Benchmarks
Price Chart
18
Health
Poor
Bearish
auto_awesome

Analytical Summary

Catheter Precision, Inc. faces fundamental challenges. The fundamentals warrant careful consideration of downside risks.

Market Cap
Dividend Yield
Revenue Growth 380.7%
Op. Margin -388.1%
ROIC -20.6%
FCF / Share $-1.04
Trailing P/E
Price / Book 0.0x
FCF Yield
Debt / Equity
info Valuation on last close. End-of-day price, Sep 22, 2026.

38-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$1.02M
↑ +380.7%
Net Income Profit after all expenses
$-3.29M
↑ +35.5%
Operating Margin Operating profit as % of sales
-388.1%
↓ -66.7%
FCF / Share Free cash flow per share
$-1.04
↑ +18.7%
Long-Term Debt Long-term obligations
$3.08M
↑ +105.2%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns
1
Financial Health
29
Cash Quality
39

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 10 years · 38 quarters